US EditionPublished • loading... • Updated
BARISTA trial demonstrates positive one-year results in treatment of illac artery lesions
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
BARISTA trial demonstrates positive one-year results in treatment of illac artery lesions
Restorer bare metal stent iVascular has announced the one-year results from the BARISTA trial, the first clinical trial with Restorer bare metal stent evaluating its safety and efficacy in the treatment of iliac artery lesions. The study provides evidence supporting the performance of Restorer across a broad spectrum of lesion complexity, from TASC A to TASC D. The BARISTA trial, led by Lieven Maene (Onze Lieve Vrouw, Aalst, Belgium), enrolled 2…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
